Early brain changes in people at risk for brain disease
Part of Brain & nervous system clinical trials.
This study looks at early signs of brain diseases like Alzheimer's or Parkinson's before symptoms appear. It uses brain scans and blood tests to find markers that might help predict who will develop these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be able to have an MRI scan with a contrast dye called Gadobutrol.
- You must be willing to have blood drawn and undergo a brain MRI.
- You must be okay with being told if the MRI shows an unexpected medical issue.
- You must not have symptoms of a brain disease already.
- You must be either a carrier or relative of someone with a genetic mutation linked to brain disease, or have certain early risk signs like REM sleep behavior disorder, or be a healthy control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new imaging agent that helps doctors see brain changes related to Alzheimer's, Parkinson's, and similar conditions. The goal is to improve diagnosis and monitoring of these diseases.
This study tracks changes in people with Parkinson's disease, other movement disorders, or cognitive decline to find better ways to measure disease progression.
This study aims to improve MRI scan settings used when studying brain diseases that affect memory and movement. You would be asked to undergo MRI scanning as a healthy volunteer to help optimize the imaging process.
This extension study looks for predictors—measurable clues—linked to memory changes in older adults who feel their memory is worsening. You may be asked to have an amyloid PET scan, which can help researchers understand what might be driving memory concerns.
This study uses brain scans (MRI and PET) to look at a tiny brain region called the locus coeruleus, which may show early signs of Alzheimer's disease. Researchers want to see if changes in this area are linked to thinking skills and future memory decline.
This study uses MRI brain scans and memory tests to help detect early Alzheimer’s disease. It compares people with Alzheimer’s (diagnosed by a clinician) with people without memory problems to see which scan and test results stand out.
Hear when a new Neurodegenerative Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.